Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10796253rdf:typepubmed:Citationlld:pubmed
pubmed-article:10796253lifeskim:mentionsumls-concept:C0016860lld:lifeskim
pubmed-article:10796253lifeskim:mentionsumls-concept:C0021270lld:lifeskim
pubmed-article:10796253lifeskim:mentionsumls-concept:C0013274lld:lifeskim
pubmed-article:10796253lifeskim:mentionsumls-concept:C0231220lld:lifeskim
pubmed-article:10796253pubmed:issue2lld:pubmed
pubmed-article:10796253pubmed:dateCreated2000-7-6lld:pubmed
pubmed-article:10796253pubmed:abstractTextInhibition of prostaglandin synthesis mediates closure of the ductus arteriosus and renal side effects after indomethacin administration. Because furosemide increases prostaglandin production, it could potentially help prevent indomethacin-related toxicity but also decrease ductal response to indomethacin.lld:pubmed
pubmed-article:10796253pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10796253pubmed:languageenglld:pubmed
pubmed-article:10796253pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10796253pubmed:citationSubsetIMlld:pubmed
pubmed-article:10796253pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10796253pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10796253pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10796253pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10796253pubmed:statusMEDLINElld:pubmed
pubmed-article:10796253pubmed:issn1469-493Xlld:pubmed
pubmed-article:10796253pubmed:authorpubmed-author:CampbellD EDElld:pubmed
pubmed-article:10796253pubmed:authorpubmed-author:BrionL PLPlld:pubmed
pubmed-article:10796253pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10796253pubmed:ownerNLMlld:pubmed
pubmed-article:10796253pubmed:authorsCompleteYlld:pubmed
pubmed-article:10796253pubmed:paginationCD001148lld:pubmed
pubmed-article:10796253pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:meshHeadingpubmed-meshheading:10796253...lld:pubmed
pubmed-article:10796253pubmed:year2000lld:pubmed
pubmed-article:10796253pubmed:articleTitleFurosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.lld:pubmed
pubmed-article:10796253pubmed:affiliationPediatrics, Division of Neonatology, Albert Einstein College of Medicine and Montefiore Medical Center, Weiler Hospital Room 725, 1825 Eastchester Road, Bronx, NY 10461, USA. brion@aecom.yu.edulld:pubmed
pubmed-article:10796253pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10796253pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10796253lld:pubmed